Comparison of antibody monitoring system with flow cytometric crossmatch test in renal transplant recipients with high panel-reactive antibody

Nephron - Clinical Practice

Volumn 111, Issue 4, 2009, Pages

  Hwang, Hyeon Seok ^a   Hyoung, Bok Jin ^a   Lee, So Young ^a   Jeon, Youn Joo ^a   Yoon, Hye Eun ^a   Kim, Jin Young ^a   Choi, Bum Soon ^a   Oh, Eun Jee ^a   Kim, Yong Soo ^a   Bang, Byung Kee ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antibody monitoring system; Flow cytometric crossmatch; High panel reactive antibody

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PANEL REACTIVE ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA MATCHING; HLA SYSTEM; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECIPIENT;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA-D ANTIGENS; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MONITORING, IMMUNOLOGIC;

EID: 62049084332     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209153     Document Type: Article

References (17)

1. Feucht HE: Significance of donor-specific antibodies in acute rejection. Transplant Proc 2005; 37: 3693-3694.
2. Piazza A, Poggi E, Borrelli L, et al: Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation. Transplantation 2001; 71: 1106-1112.
3. Saidman S: Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival. Transplant Proc 2007; 39: 744-746.
4. Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, Pochinco D, Birk P, Nickerson P: Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001; 12: 2807-2814.
5. Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLAspecific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003; 3: 1488-1500.
6. Patel AM, Pancoska C, Mulgaonkar S, Weng FL: Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7: 2371-2377.
7. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC: Detection of donorspecific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625-2629.
8. Singh D, Kiberd BA, West KA, Kamal K, Balbontin F, Belitsky P, Lawen J: Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients. Transplant Proc 2003; 35: 2395-2397.
9. Lieber SR, Perez FVT, Tabossi MR, Persoli LBL, Marques SBD, Mazzali M, Alves-Filho G, Souza CA: Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients. Transplant Proc 2007; 39: 429-431.
10. Yang CW, Oh EJ, Lee SB, Moon IS, Kim DG, Choi BS, Park SC, Choi YJ, Park YJ, Han K: Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Transplant Proc 2006; 38: 2803-2806.
11. Suciu-Foca N, Reed E, D'Agati VD, Ho E, Cohen DJ, McCabe R, Brensilver JM, King DW, Hardy MA: Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51: 593-601.
12. Fernández-Fresnedo G, Pastor JM, López-Hoyos M, et al: Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival after renal transplantation. Nephrol Dial Transplant 2003; 18: 990-995.
13. Lee KW, Kim SJ, Lee DS, Lee HH, Joh JW, Lee SK, Oh HY, Kim DJ, Kim YG, Huh WS, Oh WI, Lee BB: Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation. Transplant Proc 2004; 36: 2009-2010.
14. Delgado JC, Eckels DD: Positive B-cell only flow cytometric crossmatch: implications for renal transplantation. Exp Mol Pathol 2008; 85: 59-63.
15. Lobashevsky AL, Senkbeil RW, Shoaf J, Mink C, Rowe C, Lobashevsky ES, Burke R, Hudson S, Deierhoi MH, Thomas JM: Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Clin Transplant 2000; 14: 533-542.
16. Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RWG: Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75: 1034-1040.
17. Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD: Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804-2812.